Table 2 Pharmacological treatments during hospital stay and at discharge.
| ACS with unstable angina (n = 268) | ACS with myocardial necrosis (n = 530) | ACS with clinical MI (n = 1686) | p Value | |
|---|---|---|---|---|
| In hospital | ||||
| Unfractionated heparin | 8 (3%) | 23 (4%) | 252 (15%) | <0.001 |
| LMWH | 192 (72%) | 401 (76%) | 1230 (73%) | NS |
| Clopidogrel | 118 (44%) | 290 (55%) | 866 (52%) | 0.033 |
| Glycoprotein IIb/IIIa inhibitor | 3 (1%) | 36 (7%) | 121 (7%) | 0.004 |
| Intravenous β blocker | 1 (0.4%) | 5 (1%) | 32 (2%) | NS |
| Calcium antagonist | 77 (29%) | 116 (22%) | 319 (19%) | 0.005 |
| Intravenous nitrate | 12 (5%) | 56 (11%) | 320 (19%) | <0.001 |
| Oral nitrate | 142 (53%) | 262 (49%) | 726 (43%) | 0.007 |
| Potassium channel modulator | 62 (23%) | 115 (22%) | 227 (14%) | <0.001 |
| After discharge | ||||
| β Blocker | 139 (53%) | 277 (53.1 %) | 1106 (66%) | <0.001 |
| Statin | 181 (69%) | 358 (68.5 %) | 1350 (80%) | <0.001 |
| ACE inhibitor | 121 (46%) | 276 (52.8 %) | 1094 (65%) | <0.001 |
| Aspirin | 190 (72%) | 362 (69.1 %) | 1327 (79%) | <0.001 |
| Clopidogrel | 85 (32%) | 224 (42.3%) | 651 (39%) | 0.004 |
ACE, angiotensin converting enzyme; LMWH, low molecular weight heparin.